| A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer | |
| Zhou, Tie; Zeng, Shu-xiong; Ye, Ding-wei; Wei, Qiang; Zhang, Xu; Huang, Yi-ran; Ye, Zhang-qun; Yang, Yong; Zhang, Wei; Tian, Ye | |
| 2015 | |
| 卷号 | 10期号:1页码:e0117002 |
| ISSN号 | 1932-6203 |
| DOI | 10.1371/journal.pone.0117002 |
| URL标识 | 查看原文 |
| 收录类别 | SCIE ; PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6661572 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhou, Tie,Zeng, Shu-xiong,Ye, Ding-wei,et al. A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer[J],2015,10(1):e0117002. |
| APA | Zhou, Tie.,Zeng, Shu-xiong.,Ye, Ding-wei.,Wei, Qiang.,Zhang, Xu.,...&Sun, Ying-hao.(2015).A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer.,10(1),e0117002. |
| MLA | Zhou, Tie,et al."A Multicenter, Randomized Clinical Trial Comparing the Three-Weekly Docetaxel Regimen plus Prednisone versus Mitoxantone plus Prednisone for Chinese Patients with Metastatic Castration Refractory Prostate Cancer".10.1(2015):e0117002. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论